WELLINGTON – New Zealanders will soon be able to access a third type of Novavax vaccine following the government’s confirmation on Monday.
COVID-19 Response Minister Chris Hipkins said on Tuesday that Novavax will soon be available to New Zealanders aged 18 and over.
“Novavax is a protein-based COVID-19 vaccine and while the Pfizer COVID-19 vaccine remains the preferred vaccine of most New Zealanders. For some people, the arrival of Novavax will be the extra incentive required to get vaccinated against COVID-19,” Hipkins said in a statement.
Read more: AstraZeneca approved as booster vaccine in Australia amid battle against COVID-19
New Zealand is already one of the most highly vaccinated countries in the world with 95 percent of people aged 12 and over being vaccinated, Hipkins said.
The first doses are anticipated to arrive in New Zealand this month, and officials are working with Novavax to confirm the delivery schedule and rollout start date, he said.
Read More News On
Catch all the Health News, Breaking News Event and Latest News Updates on The BOL News
Download The BOL News App to get the Daily News Update & Follow us on Google News.